All Editorial articles – Page 85
-
NewsInsilico Medicine deploys the first bipedal humanoid AI scientist in fully-robotic drug discovery laboratory
Insilico Medicine, a clinical-stage biotechnology company pioneering generative AI for drug discovery and development, has announced the deployment of the first bipedal humanoid in its AI-powered fully-robotic drug discovery laboratory.
-
NewsBAADesign enables the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants
BAADesign offers a powerful tool for reengineering monoclonal antibodies to combat emerging SARS-CoV-2 variants, providing a scalable solution for future pandemic preparedness, according to a new study.
-
NewsNew antibodies show potential to defeat all SARS-CoV-2 variants
Researchers discovered that a paired combination of antibodies binding to the two domains of the SARS-CoV-2 viral particle showed promising results in elimination of all virus variants caused in the COVID-19 pandemic.
-
NewsResearchers see breakthrough in efficient biofuel production
Researchers have found ways to limit the toxicity to microbes generated by the biofuel butanol through fermentation of plant biomass, by manipulating the structure of microbe cell membrane at atomic level.
-
NewsAdaptation to extreme conditions: thermal water biofilm studies could help understand ancient ecosystems
Researchers have discovered unique bacterial communities in thermal waters that may help unravel the development of stromatolites, one of Earth’s oldest rock formations.
-
NewsLonger breastfeeding linked to blood-pressure lowering effects of certain infant gut bacteria
An observational study has found that infants who had more diverse bacteria in their gut had lower childhood blood pressure, and this protective association was stronger if they were breastfed for at least six months.
-
NewsScottish biotech company Lentitek secures £1m funding to advance next generation cancer treatments
Biotech company Lentitek Ltd has secured £700,000 in private funding from Equity Gap, bringing its total investment to £1 million in the last six months. It develops manufacturing technologies for lentiviral vectors, used with CAR-T cell and gene therapies.
-
NewsScientist who deployed glowing stars to detect disease named fellow of the Royal Society of Chemistry
The man who turned the science of glow-in-the-dark stars into ways to detect disease, Professor Richard Willson, has been elected as a fellow of the Royal Society of Chemistry.
-
NewsWhite blood cells use brute force to dislodge bacteria
A $2.3 million grant from the National Institutes of Health (NIH).will support research into blood platelets and macrophages; how integrin tension influences cell function; and how this force affects platelet behavior.
-
NewsAMI member Christopher Stewart named as laureate in 2025 UK Blavatnik Awards for Young Scientists
Applied Microbiology International member Professor Christopher Stewart of Newcastle University has been named as one of three 2025 laureates in the eighth Blavatnik Awards for Young Scientists in the UK.
-
NewsScientists reveal anti-bacterial role of plant metabolite
A study shows that a plant metabolite, erucamide, is able to target and disrupt a protein assembly of Gram-negative bacterial pathogens, thus inhibiting their virulence. Understanding the metabolite’s molecular mechanisms could protect crops from infection.
-
NewsResearchers develop innovative tool for rapid pathogen detection
A powerful pipeline was developed for more efficient and accurate primer design in qPCR that accelerates the diagnostic tests for infectious diseases and facilitates researches in rapidly evolving pathogens.
-
NewsNew biosensor can detect airborne bird flu in under 5 minutes
A new biosensor for monitoring aerosol particles of H5N1 works within five minutes, preserving the sample of the microbes for further analysis and providing a range of the pathogen concentration levels detected on a farm.
-
NewsCentauri Therapeutics selects first clinical candidate for immunotherapeutic treatment of Gram-negative bacterial infections
Centauri Therapeutics Limited has announced the selection of its first clinical candidate in the ABX-01 programme. The compound is designed to target serious Gram-negative bacterial infections in the lung.
-
NewsStudy uncovers how low-carb diet drives colorectal cancer development
A new study suggests that a low-carbohydrate diet promotes the growth of a strain of E. coli that produces DNA-damaging colibactin, which drives genetic mutations and predisposes tumour development.
-
NewsA surprising link between Crohn’s disease and the Epstein-Barr virus
A longitudinal study has revealed strong and surprising evidence showing that exposure to Epstein-Barr virus (EBV) can lead to a higher risk of Crohn’s disease. Researchers are now trying to find out the mechanistic actions in their associations.
-
NewsStudy uncovers the core principles of low-resistance antibiotics
Researchers have demonstrated that a dual-target approach, combining membrane disruption with an additional critical cellular pathway, significantly prevents the development of resistance in bacteria.
-
NewsStudy: Smartwatches could end the next pandemic
Everyday smartwatches are extremely accurate in detecting viral infection long before symptoms appear — new research shows how they could help stop a pandemic before it even begins.
-
NewsCan Rhizobium + low P increase the yield of common bean in Ethiopia?
A study found that bean inoculation with Rhizobium alone or in combination with P application, can increase grain yield of two common bean cultivars in Ethiopia.
-
NewsProactively exposing ecosystems to mild environmental stressors appears to offer protection
Mild, proactive exposure to environmental stress can help biological communities resist severe disturbances and maintain genetic diversity, a recent study has found.